Silicon Motion Announces Fourth Quarter 2025 Earnings Conference Call

Silicon Motion Announces Fourth Quarter 2025 Earnings Conference Call GlobeNewswire January 09, 2026 TAIPEI, Taiwan and MILPITAS, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) — Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or the “Company”), a global leader in NAND flash controllers for solid state storage devices, plans to release its fourth quarter 2025 financial […]

Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery

Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery GlobeNewswire January 09, 2026 Company to present Tuesday, January 13th at 10:00 a.m. PT / 1:00 p.m. ET GAITHERSBURG, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix

MidCap Financial Announces Inaugural Investment Grade Financing

MidCap Financial Announces Inaugural Investment Grade Financing $3.1 Billion Unsecured Funding Offering Strengthens Capital Structure and Marks Transformational Credit Profile Enhancement GlobeNewswire January 09, 2026 BETHESDA, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) — MidCap Financial (“MidCap” or the “Company”) today announced the signing of approximately $3.1 billion of senior unsecured notes and junior subordinated notes,

NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities

NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities GlobeNewswire January 09, 2026 — EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26 — — Phase 3 PREVAIL CVOT overall event rate tracking in line with observed rate in BROADWAY — — First patient enrolled in RUBENS Phase 3 trial

ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT

ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT GlobeNewswire January 09, 2026 Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Vancouver, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) —

iAltA Holdings Acquires BridgeFT

iAltA Holdings Acquires BridgeFT Acquisition Strengthens Data Connectivity Across the Wealth and Private Markets Ecosystem GlobeNewswire January 09, 2026 NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) — iAltA Holdings, the WestCap-backed private markets infrastructure company, today announced the acquisition of BridgeFT, a cloud-native, API-first wealth infrastructure software company that enables financial institutions, fintech innovators, and

Rigetti Computing Provides Update on 108-Qubit System

Rigetti Computing Provides Update on 108-Qubit System GlobeNewswire January 09, 2026 BERKELEY, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) — Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced that it is revising its roadmap and adjusting the date for general availability of its 108-qubit quantum computing system,

Medicines360 Acquires Global Licensing Rights to Innovative Maternal Health Technologies for Risk Identification and Management Throughout Pregnancy

Medicines360 Acquires Global Licensing Rights to Innovative Maternal Health Technologies for Risk Identification and Management Throughout Pregnancy GlobeNewswire January 09, 2026 Licensing of scientific discoveries from University of Cambridge and University of Edinburgh is aimed to speed translation and access to life-saving diagnostics for women worldwide. SAN FRANCISCO, Jan. 09, 2026 (GLOBE NEWSWIRE) — Medicines360,

Crayhill and Monarch Launch Monarch JVT Funding to Provide $300 Million for Tax Credit Transfer Partnerships

Crayhill and Monarch Launch Monarch JVT Funding to Provide $300 Million for Tax Credit Transfer Partnerships GlobeNewswire January 09, 2026 ATLANTA, Jan. 09, 2026 (GLOBE NEWSWIRE) — Crayhill Capital Management (“Crayhill”) and Monarch Private Capital (“Monarch”) are pleased to announce a strategic joint venture to facilitate hybrid preferred tax equity investments for renewable energy projects,

Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor

Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor GlobeNewswire January 09, 2026 Agreement expands Madrigal's pipeline and strengthens its leadership in pioneering MASH therapies DGAT-2 inhibition represents a complementary mechanism of action with Rezdiffra(R) (resmetirom) for potential additive therapeutic benefit in MASH Madrigal to present

Scroll to Top